Search research articles
Contact Us
Filters
Showing results (211-220 of 270) with videos related to
Page
of 27
Sort By:
Cell Reports Methods
|
April 14, 2023
Diagnostic TR-FRET assays for detection of antibodies in patient samples
Hong Yue, Radosław P Nowak, Daan Overwijn, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
AIDS (London, England)
|
June 15, 2021
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria
Jesse Fajnzylber, Radwa Sharaf, John N Hutchinson, et al.
Microbiology Spectrum
|
May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution
Gregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 10, 2021
Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival
Upasana Das Adhikari, George Eng, Mara Farcasanu, et al.
AIDS Research and Human Retroviruses
|
May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary
Brigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
Nature Communications
|
August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The New England Journal of Medicine
|
June 29, 2022
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
Julie Boucau, Caitlin Marino, James Regan, et al.
Nature Communications
|
January 19, 2023
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Page
of 27
Search research articles
Search
Showing results (211-220 of 270) with videos related to
Sort By:
Page
of 27
Cell Reports Methods
|
April 14, 2023
Diagnostic TR-FRET assays for detection of antibodies in patient samples
Hong Yue, Radosław P Nowak, Daan Overwijn, et al.
Biorxiv : the Preprint Server for Biology
|
September 30, 2024
Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance
Tin Phan, Ruy M Ribeiro, Gregory E Edelstein, et al.
AIDS (London, England)
|
June 15, 2021
Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria
Jesse Fajnzylber, Radwa Sharaf, John N Hutchinson, et al.
Microbiology Spectrum
|
May 18, 2026
Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution
Gregory E Edelstein, Tatum N Sass, Rinki Deo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 10, 2021
Fecal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-Cov-2) RNA Is Associated With Decreased Coronavirus Disease 2019 (COVID-19) Survival
Upasana Das Adhikari, George Eng, Mara Farcasanu, et al.
AIDS Research and Human Retroviruses
|
May 1, 2023
Current HIV/SIV Reservoir Assays for Preclinical and Clinical Applications: Recommendations from the Experts 2022 NIAID Workshop Summary
Brigitte E Sanders-Beer, Nancie M Archin, Zabrina L Brumme, et al.
Nature Communications
|
August 22, 2022
Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Medrxiv : the Preprint Server for Health Sciences
|
February 12, 2026
Viral shedding and symptom severity across populations during acute COVID in the ACTIV-2 study
Evelyn Kung, Rinki Deo, Manish C Choudhary, et al.
The New England Journal of Medicine
|
June 29, 2022
Duration of Shedding of Culturable Virus in SARS-CoV-2 Omicron (BA.1) Infection
Julie Boucau, Caitlin Marino, James Regan, et al.
Nature Communications
|
January 19, 2023
Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19
Kara W Chew, Carlee Moser, Eric S Daar, et al.
Page
of 27